Giacomo Ruffo
Papers
1
Total Citations
14
H-Index
1
About
Giacomo Ruffo is a leading colorectal surgeon whose research focuses on optimizing surgical timing and outcomes for rectal cancer patients following neoadjuvant chemoradiotherapy. His most impactful work centers on the critical question of when to perform minimally invasive surgery after chemoradiation to maximize tumor regression and improve patient prognosis. Ruffo’s major contribution is the TiMiSNAR trial, a multicenter randomized controlled trial comparing standard 8-week versus prolonged 12-week intervals to surgery. This study, his most cited work with 14 citations, challenges conventional timelines by investigating whether a longer waiting period allows for more complete pathological response, potentially reducing recurrence and the need for more radical procedures. By addressing a long-standing clinical controversy through rigorous methodology, Ruffo has provided evidence that could reshape postoperative care protocols. His work is particularly notable for its direct impact on surgical decision-making, offering a data-driven approach to a previously subjective area. For students and researchers, Ruffo exemplifies how targeted clinical trials can resolve persistent debates in oncology, ultimately aiming to improve both survival and quality of life for rectal cancer patients.
Research Focus
Key Achievements
Top Papers
- 1